NeuroBo Pharmaceuticals Inc (NASDAQ:NRBO)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - NRBO
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - NRBO
- Market Cap$118.620m
- SymbolNASDAQ:NRBO
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS64132R1077
Company Profile
NeuroBo Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in developing and commercializing therapies for patients with diabetic neuropathy and Alzheimer's disease. Its product candidate comprises NB-01, which is primarily focused on the development of a treatment for painful diabetic neuropathy; NB-02, which treat the symptoms of neurodegenerative diseases associated with the malfunction of a protein called tau, and with amyloid-beta plaque deposition; Gemcabene, which is focused on developing and commercializing therapies for the treatment of dyslipidemia.Gemphire Therapeutics Inc is a clinical-stage biopharmaceutical company developing and commercializing therapies for the treatment of dyslipidemia, a serious medical condition that increases the risk of life threatening cardiovascular disease.
Latest NRBO news
Currently there for this company. Visit our news hub for other news .